Back to top
more

AMN Healthcare Services (AMN)

(Delayed Data from NYSE)

$42.57 USD

42.57
740,451

-0.06 (-0.14%)

Updated Sep 27, 2024 04:00 PM ET

After-Market: $42.57 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 31% (172 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why Investors Should Retain Abbott (ABT) Stock Now

by Zacks Equity Research

Strong performance across the Diabetes Care and EPD businesses is driving the top line for Abbott (ABT).

QIAGEN (QGEN) to Acquire Poland-Based Enzymes Manufacturer

by Zacks Equity Research

The latest acquisition of BLIRT will allow QIAGEN (QGEN) to tap into the high opportunities within the life science industry.

Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now

by Zacks Equity Research

Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

Doximity (DOCS) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research

Doximity's (DOCS) fiscal fourth-quarter results are likely to reflect continued strength in its telehealth platform.

BD (BDX) Extends Partnership to Boost Diagnostic Blood Collection

by Zacks Equity Research

BD (BDX) expands strategic partnership with Babson Diagnostics that will enable less invasive blood sample collection easier and patient-centric.

Here's Why You Should Hold on to Stryker (SYK) Stock for Now

by Zacks Equity Research

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.

Here's Why Investors Should Retain Medtronic (MDT) Stock

by Zacks Equity Research

Investors are optimistic about Medtronic's (MDT) rising market share gains and ongoing business recovery.

Here's Why You Should Retain LabCorp (LH) Stock for Now

by Zacks Equity Research

Investors are optimistic about LabCorp's (LH) better-than-expected earnings and robust segmental performance.

Inogen (INGN) Stock Inches Up 0.5% Post Q1 Earnings Beat

by Zacks Equity Research

Inogen's (INGN) first-quarter results benefit from higher revenues across the majority of its geographical segments and categories.

Here's Why You Should Retain Intuitive Surgical (ISRG) Stock

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to gain traction from the improving adoption of the da Vince Surgical System. Higher production costs are a woe.

3 Reasons Why AMN Healthcare (AMN) Is a Great Growth Stock

by Zacks Equity Research

AMN Healthcare (AMN) possesses solid growth attributes, which could help it handily outperform the market.

OPKO Health (OPK) Post In-Line Q1 Earnings, Revenues Top

by Zacks Equity Research

OPKO Health's (OPK) first-quarter results benefit from continued strength in its Pharmaceuticals segment.

Here's Why You Should Hold on to CVS Health (CVS) For Now

by Zacks Equity Research

Investors are optimistic about CVS Health's (CVS) better-than-expected results and strong retail sales.

Best Growth Stocks to Buy for May 10th

by Zacks Equity Research

AMN, GEO, and AA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 10, 2022.

AMN vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

AMN vs. GDRX: Which Stock Is the Better Value Option?

AMN Healthcare (AMN) Q1 Earnings, Revenues Beat Estimates

by Zacks Equity Research

AMN Healthcare's (AMN) robust Q1 results demonstrate its segmental strength.

AMN Healthcare Services (AMN) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

AMN Healthcare (AMN) delivered earnings and revenue surprises of 7.38% and 3.69%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Here's Why You Should Hold on to Edwards Lifesciences (EW) Now

by Zacks Equity Research

Investors are optimistic about Edwards Lifesciences (EW) given the strong demand for its RESILIA tissue valves and the PASCAL system.

Here's Why You Should Retain Quest Diagnostics (DGX) Stock Now

by Zacks Equity Research

Investors are optimistic about Quest Diagnostics (DGX) owing to a strong recovery in base business and raised 2022 outlook.

AMN Healthcare (AMN) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research

AMN Healthcare's (AMN) first-quarter results are likely to reflect solid demand in some of the areas of its business.

AMN Healthcare Services (AMN) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, AMN Healthcare Services (AMN) closed at $103.49, marking a -1.14% move from the previous day.

Here's Why You Should Retain Allscripts (MDRX) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.

AMN vs. GDRX: Which Stock Is the Better Value Option?

by Zacks Equity Research

AMN vs. GDRX: Which Stock Is the Better Value Option?

Here's Why You Should Retain Integra (IART) Stock For Now

by Zacks Equity Research

Investors are optimistic about Integra (IART), given the strength in its CSS arm and notable product launches.